| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/03/2003 | US20030064109 Dry hemostatic compositions and methods for their preparation |
| 04/03/2003 | US20030064097 For delivery of drugs, nutrionals, cosmeceuticals and diagnostic agents |
| 04/03/2003 | US20030064095 Microfabricated nanopore device for sustained release of therapeutic agent |
| 04/03/2003 | US20030064088 Surgically implantable and sealable drug delivery device that upon contact of its contents via an interface window or port with an organ or tissue exposes a therapeutic agent to organ or tissue surface, allowing a controlled, selective diffusion |
| 04/03/2003 | US20030064085 Cosmetic or dermatological composition comprising a combination of an elastase inhibitor of the N-acylaminoamide family and at least one myorelaxing agent |
| 04/03/2003 | US20030064078 Vaccines |
| 04/03/2003 | US20030064077 Recombinant poxvirus cytomegalovirus, compositions, and uses |
| 04/03/2003 | US20030064074 Recombinant gelatins in vaccines |
| 04/03/2003 | US20030064072 For diagnosis, therapy and prophylaxis of disorders related to the lung, including lung cancer |
| 04/03/2003 | US20030064071 Method of using a facilitator of retroviral entry into cells |
| 04/03/2003 | US20030064066 For inhibiting cell division and/or resulting in apoptosis |
| 04/03/2003 | US20030064064 Administering formulation that inhibits activity of IgE(immunoglobulin E) sufficient to decrease the activity of IgE and administering to the subject second formulation amount of the antigen sufficient to modulate the immune response |
| 04/03/2003 | US20030064063 For prophylaxis of type I hypersensitivity disease in a subject receiving immunotherapy |
| 04/03/2003 | US20030064062 For use in pharmaceuticals, diagnostics, biosensors and bioreactors |
| 04/03/2003 | US20030064053 Multivalent protein conjugate with multiple ligand-binding domains of receptors |
| 04/03/2003 | US20030064052 Useful for maintaining controlled and reliable dosage of the therapeutic agent via pulmonary delivery |
| 04/03/2003 | US20030064033 Propellant-based microparticle formulations |
| 04/03/2003 | US20030064032 Process for nebulizing aqueous compositions containing highly concentrated insulin |
| 04/03/2003 | US20030064021 Neutrophil stimulating peptides |
| 04/03/2003 | CA2820170A1 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 04/03/2003 | CA2778208A1 Delivery system for biological component |
| 04/03/2003 | CA2463039A1 1,6-naphthyridine derivatives as antidiabetics |
| 04/03/2003 | CA2461903A1 Monobactam antibacterial compounds and methods of use thereof |
| 04/03/2003 | CA2461861A1 Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
| 04/03/2003 | CA2461666A1 Combination therapies for immune mediated diseases |
| 04/03/2003 | CA2461631A1 Methods and compositions for prevention, diagnosis, and treatment of cancer using bispecific molecules |
| 04/03/2003 | CA2461526A1 Aptamers containing sequences of nucleic acids or nucleic acid analogues bound homologously, or in novel complexes |
| 04/03/2003 | CA2461477A1 Antisense oligonucleotides and methods to induce tumor cell death |
| 04/03/2003 | CA2461454A1 Assessment of neurons in the arcuate nucleus to screen for agents that modify feeding behavior |
| 04/03/2003 | CA2461421A1 Material consisting of at least a biodegradable polymer and cyclodextrins |
| 04/03/2003 | CA2461372A1 Dna sequences for human angiogenesis genes |
| 04/03/2003 | CA2461345A1 Use of pyy or agonist thereof to modify feeding behaviour |
| 04/03/2003 | CA2461305A1 Methods of suppressing microglial activation and systemic inflammatory responses |
| 04/03/2003 | CA2461144A1 Preparation and use of pyrrole derivatives for treating obesity |
| 04/03/2003 | CA2461132A1 1, 8-naphthyridine derivatives as antidiabetics |
| 04/03/2003 | CA2461091A1 Use of hmgb1 for the activation of dendritic cells |
| 04/03/2003 | CA2461007A1 Use of cardiotrophin in liver diseases |
| 04/03/2003 | CA2461003A1 Human coagulation factor vii polypeptides |
| 04/03/2003 | CA2460953A1 Proteins associated with cell growth, differentiation, and death |
| 04/03/2003 | CA2460787A1 Prevention and treatment of restenosis by local administration of drug |
| 04/03/2003 | CA2460780A1 Autologous growth factor cocktail composition, method of production and use |
| 04/03/2003 | CA2460777A1 Thrombus/thrombogenesis inhibitors |
| 04/03/2003 | CA2460541A1 Novel ligands for the hisb10 zn2+ sites of the r-state insulin hexamer |
| 04/03/2003 | CA2459999A1 Antagonists_and agonists of igf-1 receptor |
| 04/03/2003 | CA2459807A1 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 04/03/2003 | CA2456281A1 Pyrane derivatives as both ace- and nep- inhibitors |
| 04/03/2003 | CA2455117A1 Enzyme phosphorylating ser46 of p53 |
| 04/03/2003 | CA2453985A1 Receptors and membrane-associated proteins |
| 04/02/2003 | EP1298439A1 Method for screening mch receptor antagonist/agonist |
| 04/02/2003 | EP1298436A2 Beta-amyloid peptide (BAP) release inhibitor compounds for treating BAP-related diseases and methods for their identification |
| 04/02/2003 | EP1298223A2 Methods related to the A-C repeat Z-sequence upstream from the aldose reductase gene |
| 04/02/2003 | EP1298220A1 Single nucleotide polymorphisms predicting cardiovascular disease |
| 04/02/2003 | EP1298208A2 Ribozymes targeting a hiv tat sequence |
| 04/02/2003 | EP1298206A1 Use of the Factor VII-activating protease for prevention and therapy of vaso-proliferative disorders |
| 04/02/2003 | EP1298205A1 Novel lipase |
| 04/02/2003 | EP1298203A2 Diagnosis and treatment of autoimmune diseases |
| 04/02/2003 | EP1298202A2 Biological factors and neural stem cells |
| 04/02/2003 | EP1298144A2 Murine monoclonal anti-idiotype antibody 3H1 |
| 04/02/2003 | EP1298142A1 Novel gonadotropin-releasing hormone, precursor peptides thereof and genes encoding the same |
| 04/02/2003 | EP1298141A1 Interleukin-4 (IL-4) promoter sequences specifically interacting with IRF-1 and IRF-2 |
| 04/02/2003 | EP1298140A2 Mutants of bone morphogenetic proteins (BMP) |
| 04/02/2003 | EP1297851A1 Inhibition of histone deacetylase as a treatment for cardiac hypertrophy |
| 04/02/2003 | EP1297850A1 Medicinal preparations for treating sex hormone-dependent diseases |
| 04/02/2003 | EP1297847A2 Anti-CD18 antibodies in stroke |
| 04/02/2003 | EP1297844A2 Multicomponent meningococcal vaccine |
| 04/02/2003 | EP1297843A1 Method of photoreduction of hemoglobin vesicles |
| 04/02/2003 | EP1297842A1 Medicinal components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components |
| 04/02/2003 | EP1297841A1 Pancreatic langerhans beta cell proliferation promoter and apoptosis inhibitor, and screening of candidate compounds for the e drugs |
| 04/02/2003 | EP1297840A2 Methods for treating sex hormone-dependent conditions with LHRH antagonists |
| 04/02/2003 | EP1297839A1 Preventives or remedies for heart failure |
| 04/02/2003 | EP1297838A1 Pralmorelin-containing nasal drop preparations |
| 04/02/2003 | EP1297830A1 Use of alpha- or beta-amino acids, of the corresponding esters or of dipeptides of these amino acids with histidine derivatives in the prevention or treatment of tissue damage caused by a atmospheric ozone |
| 04/02/2003 | EP1297186A1 Method of screening for chemotherapeutic treatments for cancer |
| 04/02/2003 | EP1297172A2 Methods for producing modified glycoproteins |
| 04/02/2003 | EP1297167A1 Tumour-cell specific gene expression and its use in cancer therapy |
| 04/02/2003 | EP1297161A2 Methods and means for regulation of gene expression |
| 04/02/2003 | EP1297160A1 Materials and methods relating to the increase in protein activity |
| 04/02/2003 | EP1297158A2 Regulation of human eosinophil serine protease 1-like enzyme |
| 04/02/2003 | EP1297157A2 Regulation of human mast cell protease 6-like enzyme |
| 04/02/2003 | EP1297155A2 25869, a human carboxylesterase and uses thereof |
| 04/02/2003 | EP1297154A2 Regulation of human caspase-1-like protease |
| 04/02/2003 | EP1297152A2 Isolated human aminotransferase proteins, nucleic acid molecules encoding human aminotransferase proteins, and uses thereof |
| 04/02/2003 | EP1297150A2 Human kinases |
| 04/02/2003 | EP1297147A2 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 04/02/2003 | EP1297140A2 Regulation of human p2y8-like g protein-coupled receptor |
| 04/02/2003 | EP1297139A2 G-protein coupled receptor org10 |
| 04/02/2003 | EP1297137A2 Gp286 nucleic acids and polypeptides |
| 04/02/2003 | EP1297133A2 Gp354 nucleic acids and polypeptides |
| 04/02/2003 | EP1297130A2 G-protein coupled receptors |
| 04/02/2003 | EP1297129A2 Card domain containing polypeptides, encoding nucleic acids, and methods of use |
| 04/02/2003 | EP1297128A2 G-protein coupled receptors |
| 04/02/2003 | EP1297126A1 Nucleotide and amino acid sequences of a cellular inhibitor of the dna replication in the epstein-barr herpes virus |
| 04/02/2003 | EP1297125A2 Compositions and methods for treating neoplastic disease using inhibitors of laminin5beta3 |
| 04/02/2003 | EP1297122A2 Targeted chromosomal genomic alterations in plants using modified single stranded oligonucleotides |
| 04/02/2003 | EP1297121A2 Purging of cells using viruses |
| 04/02/2003 | EP1297120A2 Liver-specific gene expression cassettes, and methods of use |
| 04/02/2003 | EP1297117A1 Polynucleotides encoding human serine proteases |
| 04/02/2003 | EP1297116A2 Method for isolating and purifying a protein and resulting protein |
| 04/02/2003 | EP1297115A2 Regulation of human phosphodiesterase-like enzyme |
| 04/02/2003 | EP1297114A1 NUCLEIC ACID MOLECULES ENCODING A PROTEIN INTERACTING WITH Ser/Thr KINASE Akt |